APA (7th ed.) Citation

SJ, T., SA, D., CB, T., ME, W., & WY, L. (2012). Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling. Blood, 120(19), 4049. https://doi.org/10.1182/blood-2012-06-436675

Chicago Style (17th ed.) Citation

SJ, Taylor, Dagger SA, Thien CB, Wikstrom ME, and Langdon WY. "Flt3 Inhibitor AC220 Is a Potent Therapy in a Mouse Model of Myeloproliferative Disease Driven by Enhanced Wild-type Flt3 Signaling." Blood 120, no. 19 (2012): 4049. https://doi.org/10.1182/blood-2012-06-436675.

MLA (9th ed.) Citation

SJ, Taylor, et al. "Flt3 Inhibitor AC220 Is a Potent Therapy in a Mouse Model of Myeloproliferative Disease Driven by Enhanced Wild-type Flt3 Signaling." Blood, vol. 120, no. 19, 2012, p. 4049, https://doi.org/10.1182/blood-2012-06-436675.